EU Regulator to Discuss Moderna, Pfizer Omicron Shots Applications on September 1

Health News

(Reuters) – The European Medicines Agency (EMA) will hold an extraordinary meeting on Sept. 1 to discuss applications from Moderna and Pfizer for vaccine boosters modified to target the Omicron variant, the regulator said on Tuesday.

The new so-called bivalent shots combat the BA.1-subvariant of Omicron and the original virus first detected in China.

Britain earlier this month became the first country to clear Moderna’s shot, which is also the world’s first bivalent vaccine.

(Reporting by Radhika Anilkumar in Bengaluru; Editing by Devika Syamnath)

Source: Read Full Article

Related posts:

First-degree burn: Definition, symptoms, and treatments Certain spots on the finger signs for the diseases of nails are often As virus flares globally, new strategies target hot spots How psychotherapy can be provided in times of COVID-19 The huge and growing primary care needs of people with diabetes who have survived COVID-19